Patent intelligence · US
US 10888499
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
Patent details — US 10888499
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 12, 2021
- Expiration
- Jan 7, 2041
- Applicant
- Aquestive Therapeutics, Inc.
- Claims
- 20
- CPC classes
- A61K, A61K9/006, A61K9/7007, A61P
Quick answer
US 10888499 (Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom) is held by Aquestive Therapeutics, Inc.. Status: granted. Granted Jan 12, 2021. Expires Jan 7, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aquestive Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K9/006, A61K9/7007, A61P, A61P1/00
More from Aquestive Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427121
Enhanced delivery epinephrine compositions
granted -
US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12290597
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12023309
Enhanced delivery epinephrine compositions
granted -
US 11541002
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 11273131
Pharmaceutical compositions with enhanced permeation
granted -
US 11191737
Enhanced delivery epinephrine compositions
granted -
US 11129799
Dual lane coating
granted
Frequently asked questions
What is US patent 10888499?
US 10888499 (Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom) is held by Aquestive Therapeutics, Inc.. Status: granted. Granted Jan 12, 2021. Expires Jan 7, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10888499?
Aquestive Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 17 pharmaceutical patents for this assignee.
When does US 10888499 expire?
Our index shows an expiration date of Jan 7, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.